New possibilities in the treatment of chronic viral hepatitis

J. Fehér, G. Lengyel, E. Hegedus

Research output: Contribution to journalArticle

Abstract

The authors review the latest treatment modalities used in chronic viral (B, C, D) hepatitis and give a comprehensive survey of the literature. In chronic hepatitis B administration of nucleoside analogues (famciclovir, penciclovir, lamivudine) along with treatment with interferon-α are mentioned. In chronic hepatitis C for non-responders to interferon therapy exist and relapses, combined treatment with ribavirin and interferon is unsuccessful, combined administration of interferon and ursodeoxycholic acid is suggested. If a hepatitis D infection is added to the chronic process, a higher dose of interferon for more than a year seems to be justified.

Original languageEnglish
Pages (from-to)259-264
Number of pages6
JournalRomanian Journal of Gastroenterology
Volume6
Issue number4
Publication statusPublished - 1997

Fingerprint

Chronic Hepatitis
Interferons
Hepatitis D
Ursodeoxycholic Acid
Lamivudine
Ribavirin
Chronic Hepatitis B
Chronic Hepatitis C
Hepatitis C
Nucleosides
Recurrence
Infection

Keywords

  • Chronic viral hepatitis
  • Interferon-α
  • Nucleoside analogues
  • Therapy
  • Ursodeoxycholic acid

ASJC Scopus subject areas

  • Gastroenterology

Cite this

New possibilities in the treatment of chronic viral hepatitis. / Fehér, J.; Lengyel, G.; Hegedus, E.

In: Romanian Journal of Gastroenterology, Vol. 6, No. 4, 1997, p. 259-264.

Research output: Contribution to journalArticle

@article{bad15a57ac18438884ff4d711c14542a,
title = "New possibilities in the treatment of chronic viral hepatitis",
abstract = "The authors review the latest treatment modalities used in chronic viral (B, C, D) hepatitis and give a comprehensive survey of the literature. In chronic hepatitis B administration of nucleoside analogues (famciclovir, penciclovir, lamivudine) along with treatment with interferon-α are mentioned. In chronic hepatitis C for non-responders to interferon therapy exist and relapses, combined treatment with ribavirin and interferon is unsuccessful, combined administration of interferon and ursodeoxycholic acid is suggested. If a hepatitis D infection is added to the chronic process, a higher dose of interferon for more than a year seems to be justified.",
keywords = "Chronic viral hepatitis, Interferon-α, Nucleoside analogues, Therapy, Ursodeoxycholic acid",
author = "J. Feh{\'e}r and G. Lengyel and E. Hegedus",
year = "1997",
language = "English",
volume = "6",
pages = "259--264",
journal = "Journal of gastrointestinal and liver diseases : JGLD",
issn = "1841-8724",
publisher = "Romanian Society of Gastroenterology",
number = "4",

}

TY - JOUR

T1 - New possibilities in the treatment of chronic viral hepatitis

AU - Fehér, J.

AU - Lengyel, G.

AU - Hegedus, E.

PY - 1997

Y1 - 1997

N2 - The authors review the latest treatment modalities used in chronic viral (B, C, D) hepatitis and give a comprehensive survey of the literature. In chronic hepatitis B administration of nucleoside analogues (famciclovir, penciclovir, lamivudine) along with treatment with interferon-α are mentioned. In chronic hepatitis C for non-responders to interferon therapy exist and relapses, combined treatment with ribavirin and interferon is unsuccessful, combined administration of interferon and ursodeoxycholic acid is suggested. If a hepatitis D infection is added to the chronic process, a higher dose of interferon for more than a year seems to be justified.

AB - The authors review the latest treatment modalities used in chronic viral (B, C, D) hepatitis and give a comprehensive survey of the literature. In chronic hepatitis B administration of nucleoside analogues (famciclovir, penciclovir, lamivudine) along with treatment with interferon-α are mentioned. In chronic hepatitis C for non-responders to interferon therapy exist and relapses, combined treatment with ribavirin and interferon is unsuccessful, combined administration of interferon and ursodeoxycholic acid is suggested. If a hepatitis D infection is added to the chronic process, a higher dose of interferon for more than a year seems to be justified.

KW - Chronic viral hepatitis

KW - Interferon-α

KW - Nucleoside analogues

KW - Therapy

KW - Ursodeoxycholic acid

UR - http://www.scopus.com/inward/record.url?scp=0031457955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031457955&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 259

EP - 264

JO - Journal of gastrointestinal and liver diseases : JGLD

JF - Journal of gastrointestinal and liver diseases : JGLD

SN - 1841-8724

IS - 4

ER -